The economic impact of COVID-19 on biotech companies

Abstract

This article looks at the impact on biological and medical companies in the context of covid-19. Through linear analysis, data model plots, and variance comparisons, the study finds that the economy of the traditional medical sector continues to decline and eventually plateaus, however, the pharmaceutical as well as biological research sectors, which are associated with the epidemic, continue to rise. The advantages and disadvantages of combining the internet and healthcare are presented. Although internet healthcare is a more convenient way for people to see a doctor. Some people can even see a doctor for treatment without leaving home, but diagnosis lacks accuracy and large testing machines. And a more rational approach to healthcare must still be researched in the future.